Cosmetic Aesthetic Treatment Allergic Reactions

Allergic reactions in aesthetic treatment: rare but recognised

True allergic reactions to aesthetic treatment products are uncommon but recognised in the clinical literature. The frequency depends on the specific product, the individual patient’s immune profile, and whether the reaction is to the active product, an excipient, or another component of the treatment process. This page describes how allergic reactions present clinically, how they differ from the more common non allergic post treatment reactions, and how response and management work.

The patient safety case for understanding allergic reactions is that early recognition supports prompt management. Most allergic reactions to aesthetic treatment products are mild and self limiting; a small subset are more significant and warrant urgent clinical attention. Patient awareness of the difference helps ensure the right response.

What allergic reactions look like clinically

Allergic reactions to aesthetic treatment products typically fall into two clinical categories: localised reactions and systemic reactions.

Localised allergic reactions present as redness, itch, swelling, or rash in the area of treatment that is more pronounced and more persistent than the typical post treatment swelling. The reaction may extend slightly beyond the immediate injection sites. Onset is typically within hours to days of treatment. The reaction may resolve on its own or may benefit from antihistamine treatment. The clinical assessment distinguishes localised allergic reactions from infection, vascular issues, and normal post treatment swelling.

Systemic allergic reactions involve symptoms beyond the treatment area: generalised hives, widespread itch, swelling of the face beyond the treatment site, swelling of the throat or tongue, difficulty breathing, dizziness, or loss of consciousness. Systemic allergic reactions can range from mild generalised itch to anaphylaxis. Anaphylaxis is a medical emergency warranting immediate emergency department attendance regardless of the suspected cause.

Delayed allergic reactions can present days to weeks after treatment, particularly for some hyaluronic acid treatment products. Late onset nodules, persistent localised inflammation, or recurrent swelling in treated areas can in some cases reflect immunological response to the product. These typically require clinical assessment to distinguish from other causes.

Distinguishing allergic from non allergic reactions

Many post treatment reactions look similar superficially but have different clinical significance. Distinguishing allergic from non allergic helps the patient and the clinical team respond appropriately.

Normal post treatment reactions are localised to injection sites, peak within 24-48 hours, and resolve over days. They include mild swelling, tenderness, small bruises, and brief redness. They are not allergic reactions and do not warrant antihistamine or steroid treatment. They warrant patient awareness but typically not clinical intervention.

Localised allergic reactions extend slightly beyond injection sites, involve itch as a prominent symptom (which is unusual for normal post treatment swelling), and may persist or worsen over days rather than resolving. They warrant a same day call to the clinic for assessment and may benefit from oral antihistamine while assessment is arranged.

Localised infection can present similarly to localised allergic reaction but involves warmth, increasing tenderness, possibly fever, and skin colour change that is more red and angry than allergic. Infection requires different management (typically antibiotics) and warrants prompt clinical assessment.

Vascular issues present with skin colour change towards pale or dusky rather than red, with disproportionate pain, and may include reticulated discolouration. The vascular occlusion explainer page describes this in detail. Vascular issues warrant immediate attention and are NOT allergic reactions.

Systemic allergic reactions involve symptoms beyond the treatment area and warrant emergency department attendance regardless of the suspected cause. Throat tightness, difficulty breathing, generalised swelling, or loss of consciousness are emergencies.

Pretreatment allergy screening

The medical history review at consultation includes a discussion of known allergies and any prior reactions to medical products including aesthetic treatment products. Patients should disclose all known allergies including drug allergies, food allergies (particularly egg, fish, and other allergies relevant to some product preparations), latex allergy, and any history of allergic reactions to local anaesthetics or other clinic products.

For patients with significant allergy history, the consultation may recommend additional precautions: patch testing where appropriate, avoiding products known to be associated with cross reactivity, ensuring antihistamine and adrenaline are available during the treatment appointment, or in some cases recommending against treatment if the risk profile is unfavourable.

For patients with a history of significant adverse reaction to a specific aesthetic treatment product, that product is typically avoided. The clinical team can usually identify alternative product approaches that reduce reaction risk. Patients with prior anaphylaxis to any aesthetic treatment product require careful evaluation and may not be appropriate candidates for further aesthetic treatment.

Management of suspected allergic reactions

Mild localised allergic reactions are typically managed with oral antihistamine (cetirizine, loratadine, or similar) for 5-7 days, cool compresses to the affected area, and avoidance of further allergen exposure. The reaction typically resolves over a week.

Moderate localised reactions or persistent reactions may benefit from short course oral corticosteroid in addition to antihistamine. The treatment is prescribed by the clinic or by the patient’s GP depending on the clinical situation.

Significant systemic reactions warrant emergency department attendance. The clinic can provide assessment and initial management of mild systemic reactions, but anaphylaxis or near anaphylaxis requires resuscitation capable facilities.

For delayed onset late nodules or persistent localised inflammation, management may involve oral steroid, intralesional steroid injection, or in some cases dissolution of the implicated treatment product. The management plan is individualised based on the clinical picture.

How allergy considerations operate at Core Aesthetics

The medical history review at every consultation at Core Aesthetics covers known allergies and any prior reactions to medical products. Corey Anderson, AHPRA registered nurse (NMW0001047575), conducts this review and discusses any specific considerations that apply to the patient’s history.

The clinic carries oral antihistamine for management of mild localised reactions and adrenaline for acute systemic reactions. The clinic does not provide hospital level resuscitation capability; significant systemic allergic reactions warrant emergency department attendance.

For patients who experience suspected allergic reactions after Core Aesthetics treatment, the assessment and initial management is provided as part of the duty of care for the original treatment without additional charge. Referral to GP or emergency department is arranged where appropriate.

Clinical accountability and how this safety guidance is reviewed

The safety content on this page is written and reviewed by Corey Anderson, an AHPRA registered nurse (NMW0001047575) who has been on the AHPRA Register of Nursing and Midwifery since January 1996. The content reflects how Core Aesthetics communicates safety information in clinical practice and is intended to inform the consultation conversation rather than to replace it. Results vary between individuals, and the descriptions of typical risks, signs, and responses refer to the centre of clinical experience rather than to what every patient will encounter.

Specific to allergic reaction content: this page is educational and intended to support patient awareness. The clinical decisions about specific allergy precautions, product selection, and management of any suspected reaction are made at consultation based on the individual patient’s history and clinical picture. Patients with significant allergy history should disclose this at consultation rather than rely on general written content.

Patients reading this page can verify Corey Anderson’s AHPRA registration on the AHPRA public register at ahpra.gov.au using registration number NMW0001047575. The Core Aesthetics clinic operates from 12A Atherton Road, Oakleigh VIC 3166, Tuesday to Saturday, by consultation appointment. All new patient treatment at Core Aesthetics follows a structured clinical consultation, consistent with the September 2025 AHPRA cosmetic procedures guidelines. The patient safety aesthetic treatments page covers the broader safety framework, and the team page covers the practitioner background.